- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 36.06M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $27.28M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $27.21M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $132.65M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $138.61M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $47.79M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $46.27M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $104.67M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $102.52M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $215.47M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $219.23M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $373.87M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $379.32M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 38.54M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $4.66M |
| Capex | Q1 2025 · Mar 31, 2024 | $668K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$3.97M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $321.89M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $344.6M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.40 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.40 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $9.54M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $6.21M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$15.42M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$9.39M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $6.36M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $37.08M |